The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial - The ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Gangs are increasingly hiding drugs in liquids to avoid dog teams and scanners, the International Chamber of Shipping warns ...

The silence in their home is heartbreaking. The Mignosa family has gone four months without their lab, Cooper—four months ...

Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding ...

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

Relators made their showing—that Janssen Products' off-label marketing plan was nationwide in scope—by presenting a multitude ...

The U.S. has revoked the visas of members of Los Alegres del Barranco, after the Mexican band flashed big-screen images of a ...

Mexican corrido band Los Alegres del Barranco had its members' visas canceled by the U.S. government after it displayed ...

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

The author would like to recognize and thank Sakina Yasmin Naqvi for contributing to this article. National Library of Medicine: DailyMed. Arixtra—fondaparinux sodium injection, solution [drug label].